[The partial cure represents an intermediate endpoint on the path to a functional cure, not an ideal endpoint]. [PDF]
Zhuang H.
europepmc +1 more source
[A clinically cured case of chronic hepatitis B]. [PDF]
Zhang YQ, Zhang ZY, Li XX, Li MH.
europepmc +1 more source
[Chinese expert consensus on clinical practice of chronic hepatitis B functional (clinical) cure]. [PDF]
Author Group of Expert Consensus.
europepmc +1 more source
[Clinical cure and safe drug withdrawal in chronic hepatitis B]. [PDF]
Hu JL +7 more
europepmc +1 more source
[Research progress on B cells in chronic hepatitis B]. [PDF]
Tang LL, Xu RN, Wang FS.
europepmc +1 more source
[Research progress on predictive indicators of a clinical cure for chronic hepatitis B]. [PDF]
Zhang RY +7 more
europepmc +1 more source
[Research progress on new drugs for the treatment of chronic hepatitis B virus infection]. [PDF]
Yu YY, Li J, Wang WX, Fan PY, Wang FS.
europepmc +1 more source
[Reflections on the novel definition and whether or not antiviral therapy for inactive HBsAg carrier state in the "Guidelines for the Prevention and Treatment of Chronic Hepatitis B (version 2022)"]. [PDF]
Ren S, Zheng SJ, Chen XY.
europepmc +1 more source
[Introduction of the key update points of the 2025 Canadian Association for the Study of the Liver guideline for the management of chronic hepatitis B]. [PDF]
Zhuang H.
europepmc +1 more source
[A case of chronic hepatitis B in the treatment of tenofovir amibufenamide]. [PDF]
Li J, Fu MY, Zhu YF.
europepmc +1 more source

